Behzad Pavri

Dr. Behzad Pavri


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2008 in Circulation
Verified
Journal Article
Closed access
PDF file
BPBehzad Pavri
Behzad Pavri
MHMatthew B Hillis
Matthew B Hillis
HSHaris Subacius
Haris Subacius
GBGenevieve E Brumberg
Genevieve E Brumberg
ASAndi Schaechter
Andi Schaechter
DIDefibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Background— The planar QRS-T angle can be easily obtained from standard 12-lead ECGs, but its predictive ability is not established. We sought to determine the predictive ability of the planar QRS-T angle in patients with nonischemic cardiomyopathy and to assess QRS-T angle behavior over time. Methods and Results— Baseline QRS-T angles from 455 patients in the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial were measured. All patients had nonischemic cardiomyopathy, New York Heart Association class I to III heart failure, and nonsustained ventricular tachycardia or frequent ventricular ectopy. The primary end point (a composite of total mortality, appropriate implantable cardioverter-defibrillator shock, or resuscitated cardiac arrest) occurred in 25 of 172 patients (14.5%) with a QRS-T angle ≤90° and in 72 of 283 patients (25.4%) with a QRS-T angle >90° (hazard ratio, 1.93; 95% confidence interval, 1.23 to 3.05; P =0.002). A QRS-T angle >90° remained a significant predictor of the primary end point ( P =0.039) after adjustment for treatment group, age, gender, QRS duration, left bundle-branch block, left ventricular ejection fraction, New York Heart Association class III, atrial fibrillation, and diabetes mellitus. The secondary end point (total mortality) occurred in 17 of the 172 patients (9.9%) with a QRS-T angle ≤90° and in 49 of the 283 patients (17.3%) with a QRS-T angle >90° (hazard ratio, 1.79; 95% confidence interval, 1.03 to 3.10; P =0.016). A sample of 152 patients with multiple follow-up ECGs was analyzed to assess temporal QRS-T angle behavior. Changes in the QRS-T angle correlated with changes in left ventricular ejection fraction and QRS duration over time ( P 90° is a significant predictor of a composite end point of death, appropriate implantable cardioverter-defibrillator shock, or resuscitated cardiac arrest in nonpaced, mild to moderately symptomatic patients with nonischemic cardiomyopathy with frequent or complex ventricular ectopy. QRS-T angles changed predictably with left ventricular ejection fraction and QRS duration.

1 September 2020 in Heart Rhythm
Verified
Journal Article
Closed access
BPBehzad Pavri
Behzad Pavri
JKJuergen Kloo
Juergen Kloo
DFDarius Farzad
Darius Farzad
JRJoshua M. Riley
Joshua M. Riley

3 June 2021 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
RTR. Maynes Tatum
R. Maynes Tatum
EMElizabeth J. Maynes
Elizabeth J. Maynes
CWChelsey T. Wood
Chelsey T. Wood
ADAvijit K. Deb
Avijit K. Deb
MAMelissa A. Austin
Melissa A. Austin
SPS. Pavri
S. Pavri

1 December 2023 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
AGAishwarya Gulati
Aishwarya Gulati
VGVaibhav Gulati
Vaibhav Gulati
RHRay Hu
Ray Hu
PRPrabhakar Rajiah
Prabhakar Rajiah
JSJadranka Stojanovska
Jadranka Stojanovska
BSBaskaran Sundaram
Baskaran Sundaram
Mitral annular disjunction (MAD) refers to atrial displacement of the hinge point of the mitral valve annulus from the ventricular myocardium. MAD leads to paradoxical expansion of the annulus in systole and may often be associated with mitral valve prolapse (MVP), leaflet degeneration, myocardial and papillary muscle fibrosis, and, potentially, malignant cardiac arrhythmias. Patients with MAD and MVP may present similarly, and MAD is potentially the missing link in explaining why some patients with MVP experience adverse outcomes. Patients with a 5 mm or longer MAD distance have an elevated risk of malignant cardiac arrhythmia compared with those with a shorter MAD distance. Evaluation for MAD is an important component of cardiac imaging, especially in patients with MVP and unexplained cardiac arrhythmias. Cardiac MRI is an important diagnostic tool that aids in recognizing and quantifying MAD, MVP, and fibrosis in the papillary muscle and myocardium, which may predict and help improve outcomes following electrophysiology procedures and mitral valve surgery. This article reviews the history, pathophysiology, controversy, prevalence, clinical implications, and imaging considerations of MAD, focusing on cardiac MRI. Keywords: MR-Dynamic Contrast Enhanced, Cardiac, Mitral Valve, Mitral Annular Disjunction, Mitral Valve Prolapse, Floppy Mitral Valve, Cardiac MRI, Arrhythmia, Sudden Cardiac Death, Barlow Valve © RSNA, 2023.

15 December 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
AGAnshul Gupta
Anshul Gupta
BPBehzad Pavri
Behzad Pavri

29 April 2015 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
NJNikhil P. Joshi
Nikhil P. Joshi
MSMatthew M. Stopper
Matthew M. Stopper
JLJianqing Li
Jianqing Li
JBJohn F. Beshai
John F. Beshai
BPBehzad Pavri
Behzad Pavri